Stocklytics Platform
Asset logo for symbol OCGN
Ocugen
OCGN58
$0.77arrow_drop_up0.20%$0.00
Penny Stock
Asset logo for symbol OCGN
OCGN58

$0.77

arrow_drop_up0.20%

Performance History

Chart placeholder
Key Stats
Open$0.75
Prev. Close$0.76
EPS-0.19
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$225.56M
PE Ratio-
LOWHIGH
Day Range0.73
0.79
52 Week Range0.34
2.10
Ratios
EPS-0.19

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Ocugen (OCGN)

Ocugen Inc (OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies to treat rare and underserved eye diseases. The company's primary product candidate is OCU400, a gene therapy product for the treatment of inherited retinal diseases. OCU400 has shown promising results in preclinical studies and is expected to enter clinical trials in the near future. Ocugen also has a collaboration agreement with Bharat Biotech to develop and commercialize a COVID-19 vaccine candidate, COVAXIN, in the United States. The company has exclusive rights to the vaccine candidate in the US market.
In terms of its stock price history, Ocugen has experienced significant volatility. The stock had a 52-week high of $18.77 and a 52-week low of $0.17. As of the latest trading session, the stock is trading in a day range of $1.20 to $1.40. The trading volume for Ocugen's stock has also been relatively high, indicating strong investor interest in the company. Despite the volatility, Ocugen has managed to maintain a market cap of around $500 million, reflecting investor confidence in its potential.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Shankar Musunuri M.B.A., MBA, Ph.D.
Headquarters
Malvern
Employees
84
Exchange
NASDAQ
add Ocugen  to watchlist

Keep an eye on Ocugen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Ocugen 's (OCGN) price per share?

The current price per share for Ocugen (OCGN) is $0.77. The stock has seen a price change of $0 recently, indicating a 0.21% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Ocugen (OCGN)?

For Ocugen (OCGN), the 52-week high is $2.1, which is 171.86% from the current price. The 52-week low is $0.34, the current price is 124.43% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Ocugen (OCGN) a growth stock?

Ocugen (OCGN) has shown an average price growth of -4.38% over the past three years. It has received a score of 21 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Ocugen as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Ocugen (OCGN) stock price performance year to date (YTD)?

As of the latest data, Ocugen (OCGN) has a year-to-date price change of 17.75%. Over the past month, the stock has experienced a price change of -15.7%. Over the last three months, the change has been -30.24%. Over the past six months, the figure is -39.74%. Looking at a longer horizon, the five-year price change stands at 91.19%.
help

Is Ocugen (OCGN) a profitable company?

Ocugen (OCGN) has a net income of -$63.08M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 88.34% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.17K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $6.04M, although specific revenue growth data is currently not available. The gross profit is $5.33M. Operating income is noted at -$65.53M. Furthermore, the EBITDA is -$50.53M.
help

What is the market capitalization of Ocugen (OCGN)?

Ocugen (OCGN) has a market capitalization of $225.57M. The average daily trading volume is 0.77, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level